Journals / Journal of Istanbul Veterinary Sciences / 2021 / Cilt: 5 - Sayı: 1

Canine transmissible veneral tumor:etiology, diagnosis and treatment

Pages
57–65
Publication Date
2021-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, etiology, clinical findings, diagnosis and treatment of TVT are presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Transmissible venereal tumor (TVT) is a round cell type neoplasia that is transmitted by mating and physical transfer of tumor cells.
📊
Key Findings & Data:Initially, the small tumor forms into a large ulcerated mass in the next periods.
💡
Conclusion & Impact:In this review, etiology, clinical findings, diagnosis and treatment of TVT are presented.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Dog · Neoplasia · Vagina

Abstract

Transmissible venereal tumor (TVT) is a round cell type neoplasia that is transmitted by mating and physical transfer of tumor cells. It is one of the most common benign tumors in dogs that can be seen in both gender. The external genital area is the main location of the tumor. However, internal organ metastasis has been reported. The most common clinical signs are lobular masses which are seen in the caudal part of the penis, in the posterior region of the vagina and at the vestibulovaginal junction. Nodular lesions with rapid bleeding are the most pronounced clinical finding. Initially, the small tumor forms into a large ulcerated mass in the next periods. Simultaneously, the volume of the tumor increases and the lesions are seen multilobular, cauliflower-like, brittle, hyperemic, and hemorrhagic. The most practical diagnostic method of the tumor is vaginal cytology. Cytology findings are characterized by the round or oval cells which have, pale blue or colorless cytoplasm with cytoplasmic vacuoles and a prominent nucleus. Chemotheraphy is the most effective treatment method. The weekly intravenous administration of vincristine suplhate given for 3 weeks on average reveals that the treatment success rate is beyond 90%. In this review, etiology, clinical findings, diagnosis and treatment of TVT are presented.

🔖

Cite This Article

KÜÇÜKBEKİR, Ç. N., UÇMAK, Z. G., TEK, Ç. (2021). Canine transmissible veneral tumor:etiology, diagnosis and treatment. Journal of Istanbul Veterinary Sciences, Cilt: 5 - Sayı: 1, 57–65. https://ajindex.com/articles/229729

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Abedin, S.N. (2020). Canine transmissible venereal tumor: A review. Journal of Entomology and Zoology Studies, 8(2): 596-599.
  2. Albanese., F, Poli, A., Millanta, F. & Abramo, F. (2002). Primary cutaneous extragenital canine transmissible venereal tumour with Leishmania laden neoplastic cells: a further suggestion of histiocytic origin. Veterinary Dermatology, 13: 243-246.
  3. Allen, S.W., Prasse, K.W. & Mahaffey, E.A. (1986). Cytologic differentiation of benign from malignant canine mammary tumours. Veterinary Pathology, 23: 649-655.
  4. Amber, E.I., Henderson, R.A., Adeyanju, J.B. & Gyang, E.O. (1990). Single‐Drug Chemotherapy of Canine Transmissible Venereal Tumor with Cyclophosphamide, Methotrexate, or Vincristine. Journal of Veterinary Internal Medicine, 4: 144-147.
  5. Andrade, S.F., Sanches, O.C., Gervazoni, E.R., Lapa, F.A.S. & Kaneko, V.M. (2009). Comparação entre dois protocolos de tratamento do tumor venéreo transmissível em cães. Clínica Veterinária, 14(82), 56-62.
  6. Aprea, A.N., Allende, M.G. & Idiard, R. (1994). Tumor Venéreo Transmisible Intrauterino: descripción de un caso. Veterinaria Argentina XI, 103:192-194.
  7. Ayala-Diaz, S., Medina, D.A.V., Lizano, M. & Manzo-Merino, J. (2017). Transmissible Cancer: A Canine Transmissible Venereal Tumor during Pregnancy, Case Report. Journal of Cancer Research, 1(1); 1-4.
  8. Bancroft, J.D. & Stevens, A. (1996). Theory and Practice of Histological Techniques. 3rd ed. Batamuzi, E.K. & Kristensen, F. (1996). Urinary tract infection: the role of canine transmissible venereal tumour. Journal of Small Animal Practice, 37: 276-279.
  9. Behera, S.K., Kurade, N.P., Monsang, S.W., Das, D.P. & Mishra, K.K. (2012). Clinico-pathological findings in a case of canine cutaneous metastatic transmissible venereal tumor. Veterinarski Arhiv, 82(4): 401 – 410. Birhan, G. & Chanie, M. (2015). A Review on Canine Transmissible Venereal Tumor: from Morphologic to Biochemical and Molecular Diagnosis. Academic Journal of Animal Diseases, 4(3): 185-195.
  10. Boscos, C.M. & Ververidis, H.N. (2004, October 6-9). TVT-Clinical findings, diagnosis and treatment. In: Proceedings of the 29th World Congress of the World Small Animal Veterinary Association. Rhodes, Greece. Boyd, J. (1983). The mechanisms relating to increases in plasma enzymes and isoenzymes in diseases of animals. Veterinary Clinical Pathology, 12, 9-24. Brandão, C.V.S., Borges, A.G., Ranzani, J.J.T., Rahal, S.C., Teixeira, C.R. & Rocha, N.S. (2002). Tumor venéreo transmissível: estudo retrospectivo d